271 related articles for article (PubMed ID: 29695236)
1. Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis.
Schwarzkopf L; Witt S; Waelscher J; Polke M; Kreuter M
Respir Res; 2018 Apr; 19(1):73. PubMed ID: 29695236
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
Frank AL; Kreuter M; Schwarzkopf L
Respir Med; 2019 Jun; 152():25-31. PubMed ID: 31128606
[TBL] [Abstract][Full Text] [Related]
3. Assessing the lung cancer comorbidome: An analysis of German claims data.
Murawski M; Walter J; Schwarzkopf L
Lung Cancer; 2019 Jan; 127():122-129. PubMed ID: 30642540
[TBL] [Abstract][Full Text] [Related]
4. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
5. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases.
King C; Nathan SD
Curr Opin Pulm Med; 2013 Sep; 19(5):466-73. PubMed ID: 23912191
[TBL] [Abstract][Full Text] [Related]
6. Comorbidities in unclassifiable interstitial lung disease.
Prior TS; Hyldgaard C; Torrisi SE; Kronborg-White S; Ganter C; Bendstrup E; Kreuter M
Respir Res; 2022 Mar; 23(1):59. PubMed ID: 35296320
[TBL] [Abstract][Full Text] [Related]
7. Association of Cardiovascular Disease With Respiratory Disease.
Carter P; Lagan J; Fortune C; Bhatt DL; Vestbo J; Niven R; Chaudhuri N; Schelbert EB; Potluri R; Miller CA
J Am Coll Cardiol; 2019 May; 73(17):2166-2177. PubMed ID: 30846341
[TBL] [Abstract][Full Text] [Related]
8. Cost drivers in the pharmacological treatment of interstitial lung disease.
Maqhuzu PN; Kreuter M; Bahmer T; Kahn N; Claussen M; Holle R; Schwarzkopf L
Respir Res; 2021 Aug; 22(1):218. PubMed ID: 34344376
[TBL] [Abstract][Full Text] [Related]
9. Hospitalisation patterns of patients with interstitial lung disease in the light of comorbidities and medical treatment - a German claims data analysis.
Wälscher J; Witt S; Schwarzkopf L; Kreuter M
Respir Res; 2020 Mar; 21(1):73. PubMed ID: 32216792
[TBL] [Abstract][Full Text] [Related]
10. Impact of chronic ischemic heart disease on the health care costs of COPD patients - An analysis of German claims data.
Schwarzkopf L; Wacker M; Ertl J; Hapfelmeier J; Larisch K; Leidl R
Respir Med; 2016 Sep; 118():112-118. PubMed ID: 27578479
[TBL] [Abstract][Full Text] [Related]
11. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of comorbidities in COPD patients by disease severity in a German population.
Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
14. Primary data, claims data, and linked data in observational research: the case of COPD in Germany.
Mueller S; Gottschalk F; Groth A; Meeraus W; Driessen M; Kohlmann T; Wilke T
Respir Res; 2018 Aug; 19(1):161. PubMed ID: 30165860
[TBL] [Abstract][Full Text] [Related]
15. Patient and Therapeutic Profiles of Pulmonary Hypertension in Chronic Lung Diseases in Japan: A Cohort Study Using a Claims Database.
Kitahara K; Omura J; Wada S; Kim SW
Pulm Ther; 2024 Mar; 10(1):21-49. PubMed ID: 37950789
[TBL] [Abstract][Full Text] [Related]
16. Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy.
Fedeli U; De Giorgi A; Gennaro N; Ferroni E; Gallerani M; Mikhailidis DP; Manfredini R; Fabbian F
Int J Chron Obstruct Pulmon Dis; 2017; 12():443-450. PubMed ID: 28184156
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and prognosis of unclassifiable interstitial lung disease.
Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary Care and Prognosis in Patients With COPD and Interstitial Lung Disease Prescribed Long-Term Oxygen Therapy.
Harrison AC; Robinson JF; Tu L; McDonald CF; Khor YH
Respir Care; 2022 Jun; 67(6):667-675. PubMed ID: 35504724
[TBL] [Abstract][Full Text] [Related]
19. Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.
Szentes BL; Kreuter M; Bahmer T; Birring SS; Claussen M; Waelscher J; Leidl R; Schwarzkopf L
Respir Res; 2018 May; 19(1):101. PubMed ID: 29801506
[TBL] [Abstract][Full Text] [Related]
20. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
